Neoadjuvant chemo reduces bladder Ca mortality


Orlando, FL-After 7 years follow-up, researchers from the UnitedKingdom report that a landmark clinical trial in bladder cancer now showsa significant reduction in mortality if patients underwent 3 months of neoadjuvantchemotherapy prior to definitive surgery or radiation for muscle-invasivebladder cancer.

Recent Videos
© 2024 MJH Life Sciences

All rights reserved.